FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine, more specifically pharmacology, and concerns an agent showing endothelium-protective activity. What is offered is a dry linseed extract as an agent preventing developing endothelial dysfunction.
EFFECT: agent extends the range of product showing endothelium-protective activity.
1 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT POSSESSING ENDOTHELIUM PROTECTIVE ACTIVITY | 2014 |
|
RU2563622C1 |
| USING SECOISOLARICIRESINOL AS HAEMORHEOLOGICAL, ANTI-PLATELET AND ENDOTHELIUM-PROTECTIVE AGENT | 2013 |
|
RU2532356C1 |
| METHOD FOR ENDOTHELIAL PROTECTION WITH API-PHYTOCOMPOSITION | 2013 |
|
RU2524799C1 |
| COMPOSITION POSSESSING ENDOTHELIAL PROTECTIVE, VASODILATING AND ANGIOPROTECTIVE EFFECT | 2011 |
|
RU2464019C1 |
| METHOD OF CORRECTION OF EXPERIMENTAL GESTATIONAL TOXICOSIS BY TAURINE ADMINISTRATION | 2017 |
|
RU2672475C2 |
| MEDICATION FOR TREATMENT OF CARDIOVASCULAR DISEASES | 2014 |
|
RU2555335C9 |
| METHOD FOR SIMULATION OF ENDOTHELIAL DYSFUNCTION ASSOCIATED WITH LOW GRADATION SYSTEMIC INFLAMMATION AND OXIDATIVE STRESS | 2016 |
|
RU2618657C1 |
| METHOD FOR CORRECTION OF ENDOTHELIAL DYSFUNCTION WITH COMBINATION OF ROSUVASTATIN AND THIOCTIC ACID IN HYPOOESTROGEN-L-NAME-INDUCED NICTIC OXIDE DEFICIENCY | 2014 |
|
RU2568365C1 |
| ANTIMENOPAUSAL DRUG | 2009 |
|
RU2398592C1 |
| METHOD OF CORRECTING ENDOTHELIAL DYSFUNCTION WITH TRIMETAZIDINE IN AN ADMA-LIKE MODEL OF PREECLAMPSIA | 2018 |
|
RU2700563C1 |
